UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas.
Saved in:
| Title: | UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas. |
|---|---|
| Authors: | Liu S; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA; Department of Radiology, Stanford University, Palo Alto, CA, USA., Chai T; Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA., Garcia-Marques F; Department of Radiology, Stanford University, Palo Alto, CA, USA., Yin Q; Department of Radiology, Stanford University, Palo Alto, CA, USA., Hsu EC; Department of Radiology, Stanford University, Palo Alto, CA, USA., Shen M; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA; Department of Radiology, Stanford University, Palo Alto, CA, USA., Shaw Toland AM; Department of Pathology, Stanford University, Stanford, CA, USA., Bermudez A; Department of Radiology, Stanford University, Palo Alto, CA, USA., Hartono AB; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA., Massey CF; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA., Lee CS; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA., Zheng L; Department of Radiology, Stanford University, Palo Alto, CA, USA., Baron M; Department of Pediatrics, Stanford University, Stanford, CA, USA; Department of Genetics, Stanford University, Stanford, CA, USA., Denning CJ; Department of Radiology, Stanford University, Palo Alto, CA, USA., Aslan M; Department of Radiology, Stanford University, Palo Alto, CA, USA., Nguyen HM; Department of Urology, University of Washington, Seattle, WA, USA., Nolley R; Department of Urology, Stanford University, Stanford, CA, USA., Zoubeidi A; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V6H 3Z6, Canada., Das M; Department of Medicine, VA Palo Alto Health Care System, Palo Alto, CA, USA; Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA., Kunder CA; Department of Pathology, Stanford University, Stanford, CA, USA., Howitt BE; Department of Pathology, Stanford University, Stanford, CA, USA., Soh HT; Department of Radiology, Stanford University, Palo Alto, CA, USA; Department of Electrical Engineering, Stanford University, Stanford, CA, USA., Weissman IL; Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA; Department of Pathology, Stanford University, Stanford, CA, USA; Ludwig Center for Cancer Stem Cell Research and Medicine, Stanford University, Stanford, CA, USA., Liss MA; Department of Urology, UT Health San Antonio, San Antonio, TX, USA., Chin AI; Department of Urology, University of California, Los Angeles, Los Angeles, CA, USA., Brooks JD; Department of Urology, Stanford University, Stanford, CA, USA., Corey E; Department of Urology, University of Washington, Seattle, WA, USA., Pitteri SJ; Department of Radiology, Stanford University, Palo Alto, CA, USA., Huang J; Department of Pathology, Duke University, Durham, NC, USA., Stoyanova T; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA; Department of Radiology, Stanford University, Palo Alto, CA, USA; Department of Urology, University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: tstoyanova@mednet.ucla.edu. |
| Source: | Cell reports. Medicine [Cell Rep Med] 2024 Feb 20; Vol. 5 (2), pp. 101381. Date of Electronic Publication: 2024 Jan 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
